When non-surgical hip care is a reasonable first step

In many cases, yes: hip cartilage damage can be managed without surgery as a first step, particularly when hip symptoms are mild to moderate and the hip joint is not yet at a bone-on-bone stage. The strongest evidence here is for hip osteoarthritis, where non-surgical management is well established. For isolated focal cartilage defects, the picture is less standardised, although a 2024 review reported that activity modification, physiotherapy and injections can still play an important role in less severe cases.

The useful distinction at this stage is between symptom control and structural repair. Conservative care may reduce pain, improve walking and make day-to-day activity easier, but it does not usually mean damaged hip cartilage has grown back. That limitation is stated plainly on Lincolnshire Hip’s Arthrosamid page, which says the injection "will not regrow cartilage". Once hip arthritis is advanced, movement is markedly limited, or the joint is described as end-stage bone-on-bone, the discussion often shifts from managing symptoms to reassessing for surgery. Lincolnshire Hip presents both non-surgical and surgical routes, so the key decision is usually which stage of hip care fits the problem best.

What usually helps the hip joint first

A practical first plan for a painful hip joint is usually built over an initial 4 to 6 weeks, not around complete rest. The best-supported starting point, particularly in hip osteoarthritis, is still simple: clear advice about the problem, sensible activity changes, and a structured land-based exercise programme. OARSI’s 2019 guidance places education and exercise at the core of non-surgical care, while AAOS says physiotherapy may be considered for mild to moderate symptomatic hip osteoarthritis. In day-to-day terms, that means identifying the loads that flare the hip — for example stairs, long walks, low chairs or getting in and out of a car — and trimming those for a period while keeping the joint moving.

A good physiotherapy programme is more specific than a generic exercise sheet. AAOS rehabilitation advice focuses on strengthening the muscles that support the hip, improving flexibility, and restoring movement control; it describes an initial 4 to 6 week programme, followed by maintenance work 2 to 3 days a week. The aim is to increase tolerance gradually: better walking, easier sitting, steadier stair use, and less irritation after daily tasks. Pacing matters here. Short, regular practice is usually more useful than one hard session followed by two painful days.

This approach is not only for arthritis in later life. A 2023 review of non-arthritic hip-related pain found that over half of patients reported a satisfactory response to non-operative treatment, although the exact programme elements varied. That is why the early plan should match the reason the hip is painful, with function goals, load management and analgesia only if clinically appropriate. At Lincolnshire Hip, that practical, staged way of managing symptoms sits before any discussion of injections or operations.

Where hip injections fit and where they do not

Injections sit in the middle of the hip pathway: they may be discussed when a painful hip joint is still being managed without an operation, but they are usually aimed at symptom control rather than cartilage restoration. That distinction matters. In 2019, OARSI did not recommend routine intra-articular corticosteroid or hyaluronic acid injections for hip osteoarthritis, so the evidence does not support assuming that every injection will give durable benefit or change the course of cartilage damage.

The short-term nature of benefit is clearer in more recent data. A 2024 cohort study found that corticosteroid injections for hip arthritis gave an average of about 6.7 weeks of relief and did not delay total hip replacement by a clinically meaningful amount. In practical terms, that makes a steroid injection more plausible as a temporary pain-settling option, or sometimes a diagnostic aid, than as a way of preserving the hip joint over the long term.

That same caution applies to named products. Lincolnshire Hip includes injection options in its hip-pain pathway, and its Arthrosamid page is useful for understanding how one clinic frames a non-surgical “middle path” and which situations may rule it out, including active infection or end-stage bone-on-bone arthritis with severe limitation. But the page also states that Arthrosamid does not regrow cartilage. In other words, clinic pages can help explain pathway context and selection, yet they are not the same as broad independent guideline endorsement for routine use across every painful hip.

When your hip needs reassessment sooner

A change in pattern matters more than one bad day. For a painful hip joint, NHS advice gives clear points for stepping back in for review: pain that affects sleep, stops normal activity, keeps returning, is steadily worsening, has not improved after about 2 weeks of self-care, or morning stiffness lasting more than 30 minutes. That kind of reassessment is not a sign that conservative care has “failed”; it is the point at which clinicians may revisit the diagnosis, consider imaging, and decide whether treatment for the hip should remain non-surgical or move on.

• Routine review: arrange reassessment if the hip is limiting walking, stairs, work or sleep; if symptoms keep coming back; if home measures have not helped after 2 weeks; or if stiffness after waking lasts more than 30 minutes.
• Urgent review: seek same-day or urgent advice if severe hip pain starts suddenly, or the hip becomes hot, swollen or discoloured, or if hip pain is linked with fever or feeling generally unwell.
• Emergency assessment: after a fall or other injury, emergency care is needed if weight-bearing is not possible, walking cannot be managed, or there is tingling or loss of feeling in the hip or leg.

Within the Lincolnshire Hip pathway, that review point helps separate a flare that may still settle from a hip joint problem that may need a different test or a higher step of treatment.

When surgery becomes the more realistic hip option

The more useful distinction at this stage is between a hip joint that may still be preserved and one that has moved into established surgical disease. If pain remains severe, walking and day-to-day function stay clearly reduced, and the overall picture is advanced hip arthritis rather than a small local cartilage problem, symptom control without surgery may stop being enough to restore acceptable function. That is broadly consistent with 2024 randomised evidence: in adults aged 50 or older who already had a surgical indication for severe hip osteoarthritis, hip replacement produced greater improvement at 6 months than resistance training alone.

A different damage pattern can lead somewhere else. A 2024 review of focal hip cartilage defects noted that activity modification, physiotherapy and injections can still matter in less severe cases, so persistent focal symptoms in a younger patient may prompt a preservation-style discussion rather than an immediate replacement pathway. By contrast, diffuse arthritic wear across the joint is more likely to shift the conversation towards replacement assessment. Lincolnshire Hip describes this as a staged pathway: non-surgical care first, then a broader decision about whether the problem is still one of symptom management or has become a structural hip-joint problem that needs surgical review.

What a hip assessment at Lincolnshire Hip should clarify

By the end of a non-surgical trial, the main value of a hip assessment is clarity rather than a default move towards an injection or an operation. In a ball-and-socket hip joint, symptoms labelled as “cartilage damage” may fit early osteoarthritis, a more focal cartilage problem, another issue inside the joint, or pain that is not primarily coming from the hip at all. A proper review should also pin down what has already been tried, whether the programme was specific enough to test properly, and whether imaging is needed to guide the next decision.

That makes the endpoint of this article practical: some hips still suit monitoring or more targeted physiotherapy, some may justify a selective discussion about injections, and some need surgical referral because the problem looks structural rather than temporary. Lincolnshire Hip provides hip assessment locally in Sleaford and Grantham; it is part of the MSK Doctors group and accepts patients without referral for hip assessment.

1. [1] Treatment of hip cartilage defects in athletes. (2024). https://doi.org/10.1097/JSA.0000000000000378 https://doi.org/10.1097/JSA.0000000000000378